Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sangamo Therapeutics (SGMO) Asset Utilization Ratio (2016 - 2025)

Sangamo Therapeutics has reported Asset Utilization Ratio over the past 15 years, most recently at 0.53 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.53 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was 0.53 (changed 0.0% YoY), and the annual figure for FY2025 was 0.49, up 13.2%.
  • Asset Utilization Ratio for Q4 2025 was 0.53 at Sangamo Therapeutics, up from 0.34 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for SGMO hit a ceiling of 0.92 in Q4 2023 and a floor of 0.11 in Q2 2024.
  • Median Asset Utilization Ratio over the past 5 years was 0.27 (2022), compared with a mean of 0.38.
  • Biggest five-year swings in Asset Utilization Ratio: plummeted 80.62% in 2024 and later surged 693.74% in 2025.
  • Sangamo Therapeutics' Asset Utilization Ratio stood at 0.11 in 2021, then surged by 73.87% to 0.19 in 2022, then skyrocketed by 375.59% to 0.92 in 2023, then plummeted by 41.77% to 0.53 in 2024, then dropped by 0.0% to 0.53 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.53 (Q4 2025), 0.34 (Q3 2025), and 0.88 (Q2 2025) per Business Quant data.